An Abbott spokesman said Thursday that the company is not preparing to buy rival St. Jude Medical, a medical-device company, for $25 billion as reported by the Financial Times.
The Food and Drug Administration's approval Tuesday of the first-ever drug to increase sexual desire in women is being viewed by some as a major victory for gender equality, and for patients with a complex disorder that is often overlooked.
Medical-device makers are slow to complete studies on the safety and effectiveness of medical devices such as pacemakers, heart valves and stents after the products enter the market, according to new research. Some are never completed at all.
Before incubators won a place in U.S. hospital maternity wards, a renegade doctor had to lead a decadeslong crusade, making a sideshow display of preemies in the devices.
The selling of fetal organs and tissue is illegal under federal law. But donations are legal. In fact, an entire industry has formed around the brokerage of donations.
About 40 health systems have started venture funds. The lure is the potential for big payoffs and the promise of getting in on the ground floor with effective new healthcare technologies and services. But most startups fail to deliver on venture capitalists' investment.
Gary Fingerhut has left the Cleveland Clinic after the FBI told the hospital system that he made financial transactions that violated the hospital system's internal policies.
Nearly 160 medical specialists who frequently use magnetic resonance imaging equipment will know by mid-July how they performed on the debut version of a credentialing test evaluating knowledge of MRI safety.
Geographic disparities in access to organs remain a major issue in the U.S. Some in the transplant community say a proposal to fix the problem focuses too much on “shuffling organs” and too little on boosting low donor rates.
Hill-Rom, a Chicago-based medical equipment manufacturer, announced it will acquire Welch Allyn, a Skaneateles Falls, N.Y.-based manufacturer of diagnostic and patient-monitoring equipment.
Fitbit plans to raise up to $358 million in its initial public offering, according to a U.S. Securities and Exchange Commission filing made Tuesday. Since 2007, Fitbit has sold roughly 20.5 million of its fitness-tracking devices, with 10.9 million devices sold last year alone.
Dr. Francis “Jay” Crosson named chairman of the Medicare Payment Advisory Commission, and other news makers
Dr. Francis “Jay” Crosson has been named chairman of the Medicare Payment Advisory Commission, which advises Congress on Medicare spending.